Other grades of this product :
| Peramivir Basic information |
| Product Name: | Peramivir | | Synonyms: | (1S,2S,3R,4R)-3-(1-acetaMido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentanecarboxylic acid;3(R)-[1(S)-AcetaMido-2-ethylbutyl]-4(R)-guanidino-2(S)- hydroxycyclopentane-1(S)-carboxylic acid;PERAMIVIRUM;(1S,2S,3S,4R)-3-[(1S)-1-AcetaMido-2-ethylbutyl]-4-[(diaMinoMethylene)aMino]-2-hydroxycyclopentanecarboxylic acid;(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid;(1R,2R,3S,4S)-3-((R)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acid;Peramivir USP/EP/BP;Peramivirr | | CAS: | 229614-55-5 | | MF: | C15H28N4O4 | | MW: | 328.41 | | EINECS: | 1308068-626-2 | | Product Categories: | Amines;Chiral Reagents;Intermediates & Fine Chemicals;Isotope Labelled Compounds;Pharmaceuticals;API | | Mol File: | 229614-55-5.mol |
| Peramivir Chemical Properties |
| Peramivir Usage And Synthesis |
| Uses | Peramivir is a new antiviral agent for influenza treatment; it can be used as neuraminidase inhibitor for treating human and avian influenza
| | Pharmaceutical Applications | An intravenously administered neuraminidase inhibitor currently
under investigation for the treatment of influenza infections
in normal and high-risk patient populations. No drug
interactions of note have yet been identified. |
| Peramivir Preparation Products And Raw materials |
|